Timeline of CGRP research

The slide shows a timeline of the key events in the development of drugs that target CGRP for migraine therapy.^{[Edvinsson et al., 2018]}

Reference:
Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nat Rev Neurol 2018; 14 (6): 338–350.

Other references used on slide:
European Medicines Agency: Medicines: . https://www.ema.europa.eu/en/medicines/human/EPAR/aimovig Accessed 21 September 222

FDA Drugs@FDA: FDA-approved drugs: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/761077Orig1s000Approv.pdf Accessed 21 September 2022

FDA Drugs@FDA: FDA-approved drugs: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211765Orig1s000Approv.pdf Accessed 21 September 2022